4//SEC Filing
Douglas Earl Martin 4
Accession 0001593968-24-000196
CIK 0001737287other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:48 PM ET
Size
6.8 KB
Accession
0001593968-24-000196
Insider Transaction Report
Form 4
Douglas Earl Martin
SVP, General Counsel
Transactions
- Award
Stock Option (Right to buy)
2024-01-25+147,778→ 147,778 totalExercise: $3.20Exp: 2034-01-25→ Common Stock (147,778 underlying) - Award
Common Stock
2024-01-25+41,800→ 477,634 total
Footnotes (1)
- [F1]1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001362155
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:48 PM ET
- Size
- 6.8 KB